Theriva Biologics (TOVX) Retained Earnings (2010 - 2026)
Theriva Biologics (TOVX) posted quarterly Retained Earnings of $377000.0 for Q1 2026, up 100.11% year-over-year from $188395.3 in Q1 2025, and down 50.07% quarter-over-quarter from $755000.0 in Q4 2025.
Theriva Biologics (TOVX) Retained Earnings (2010 - 2026) Analysis & Trends
Theriva Biologics (TOVX) has reported Retained Earnings for 17 consecutive years, with $377000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Retained Earnings rose 100.11% year-over-year to $377000.0; the TTM figure through Mar 2026 stood at $377000.0 (up 100.11% YoY), while the FY2025 annual figure was $755000.0, up 164.09% from the prior year.
- Retained Earnings declined to $377000.0 in Q1 2026 per TOVX's latest filing, from $755000.0 in the prior quarter.
- Across five years, Retained Earnings topped out at $763000.0 in Q3 2025 and bottomed at -$352.0 million in Q2 2025.
- Historically, Retained Earnings has averaged -$166.1 million across 5 years, with a median of -$280.0 million in 2022.
- Annual changes were most pronounced in 2023 — Retained Earnings plunged 163330.39% — and 2025, when it surged 164.09%.
- Theriva Biologics' Retained Earnings stood at -$679000.0 in 2022, then surged by 104.71% to $32000.0 in 2023, then tumbled by 3781.25% to -$1.2 million in 2024, then soared by 164.09% to $755000.0 in 2025, then tumbled by 50.07% to $377000.0 in 2026.
- Business Quant data shows TOVX's Retained Earnings at $377000.0 in Q1 2026, $755000.0 in Q4 2025, and $763000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -6.33 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 20.91 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.57 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 4.38 Bn |
| 10 | Theriva Biologics | 10.64 Mn | 10.64 Mn | - | -364.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -364.00 Mn |
| Mar 31, 2026 | 377,000.00 |
| Dec 31, 2025 | 755,000.00 |
| Sep 30, 2025 | 763,000.00 |
| Jun 30, 2025 | -352.00 Mn |
| Mar 31, 2025 | -339.30 Mn |
| Dec 31, 2024 | -1.18 Mn |
| Sep 30, 2024 | -330.50 Mn |
| Jun 30, 2024 | -322.80 Mn |
| Mar 31, 2024 | -314.48 Mn |
| Dec 31, 2023 | 32,000.00 |
| Sep 30, 2023 | -303.83 Mn |
| Jun 30, 2023 | -356,000.00 |
| Mar 31, 2023 | -295.45 Mn |
| Dec 31, 2022 | -679,000.00 |
| Sep 30, 2022 | -284.52 Mn |
| Jun 30, 2022 | -280.03 Mn |
| Mar 31, 2022 | 181,000.00 |
| Dec 31, 2021 | -271.28 Mn |
| Sep 30, 2021 | -266.02 Mn |